Compare AYI & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AYI | ACHC |
|---|---|---|
| Founded | 2001 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | 1.3B |
| IPO Year | N/A | N/A |
| Metric | AYI | ACHC |
|---|---|---|
| Price | $363.51 | $14.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | ★ $395.17 | $24.38 |
| AVG Volume (30 Days) | 225.1K | ★ 3.4M |
| Earning Date | 01-08-2026 | 11-05-2025 |
| Dividend Yield | ★ 0.18% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 12.53 | 1.18 |
| Revenue | ★ $4,345,600,000.00 | $3,265,548,000.00 |
| Revenue This Year | $10.92 | $6.50 |
| Revenue Next Year | $5.15 | $4.38 |
| P/E Ratio | $29.90 | ★ $12.13 |
| Revenue Growth | ★ 13.14 | 4.58 |
| 52 Week Low | $216.81 | $12.63 |
| 52 Week High | $379.17 | $47.08 |
| Indicator | AYI | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 50.81 | 34.23 |
| Support Level | $367.77 | $13.60 |
| Resistance Level | $377.15 | $15.55 |
| Average True Range (ATR) | 9.75 | 0.95 |
| MACD | 0.57 | 0.08 |
| Stochastic Oscillator | 49.72 | 31.52 |
Acuity is a leading industrial technology company that offers lighting, lighting controls, and intelligent building solutions. Acuity, Inc. designs, manufactures, and brings to market products and services relating to these and other offerings. Acuity, Inc. has two reportable segments: Acuity Brands Lighting and Acuity Intelligent Spaces. ABL sells commercial, architectural, and specialty lighting, including components and control systems. AIS offers building management and audio/visual solutions to help make buildings intelligent.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.